Literature DB >> 17595432

Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease.

Maciej S Buchowski1, Larry L Swift, Sylvie A Akohoue, Sadhna M Shankar, Paul J Flakoll, Naji Abumrad.   

Abstract

BACKGROUND: The chronic hemolytic anemia experienced by sickle cell disease (SCD) patients leads to adverse effects on oxygen transport by the blood and to a decrease in oxygen availability for peripheral tissues. Limited tissue oxygen availability has the potential to modify events of intracellular metabolism and, thus, alter lipid homeostasis.
METHODS: The impact of SCD on plasma fatty acid homeostasis was determined in 8 African American SCD patients and in 6 healthy African American control subjects under postabsorptive conditions and during a 3-hour IV infusion of a nutrient solution containing lipid, glucose, and amino acids.
RESULTS: SCD patients had higher fasting levels of plasma nonesterified fatty acids (NEFA), triglycerides, and phospholipids than healthy controls. Similarly, SCD patients had higher fasting levels of fatty acids in plasma triglycerides and phospholipids than healthy controls. Infusion of nutrients resulted in equivalent plasma NEFA profiles, total NEFA, and triglycerides in SCD patients and controls. However, the plasma phospholipid concentrations and fatty acid composition of plasma triglycerides and phospholipids were significantly higher in SCD patients; in particular, plasma pools of oleic acid were consistently increased in SCD. Plasma free oleic acid levels were elevated basally, leading to increased oleic acid content in triglycerides and phospholipids both post absorptively and during nutrient infusion.
CONCLUSIONS: There is an underlying defect in lipid metabolism associated with SCD best manifested during the fasting state. This abnormality in lipid homeostasis has the potential to alter red blood cell (RBC) membrane fluidity and function in SCD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17595432      PMCID: PMC2916689          DOI: 10.1177/0148607107031004263

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  24 in total

1.  Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients.

Authors:  Katsunori Furukawa; Hideo Yamamori; Kazuya Takagi; Naganori Hayashi; Ryoji Suzuki; Nobuyuki Nakajima; Tsuguhiko Tashiro
Journal:  Nutrition       Date:  2002-03       Impact factor: 4.008

2.  A gas-liquid chromatographic assay for plasma free fatty acids.

Authors:  H Ko; M E Royer
Journal:  J Chromatogr       Date:  1974-01-30

3.  An underwater weighing system utilizing "force cube" transducers.

Authors:  R Akers; E R Buskirk
Journal:  J Appl Physiol       Date:  1969-05       Impact factor: 3.531

Review 4.  Intestinal synthesis, secretion, and transport of lipoproteins.

Authors:  C L Bisgaier; R M Glickman
Journal:  Annu Rev Physiol       Date:  1983       Impact factor: 19.318

5.  Plasma and erythrocyte lipids in sickle cell anaemia.

Authors:  J Sasaki; M R Waterman; G R Buchanan; G L Cottam
Journal:  Clin Lab Haematol       Date:  1983

6.  Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man.

Authors:  N N Abumrad; D Rabin; M P Diamond; W W Lacy
Journal:  Metabolism       Date:  1981-09       Impact factor: 8.694

7.  The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patients.

Authors:  Charles D Murray; Carel W le Roux; Catherine Gouveia; Paul Bassett; Mohammad A Ghatei; Stephen R Bloom; Anton V Emmanuel; Simon M Gabe
Journal:  Clin Nutr       Date:  2006-05-15       Impact factor: 7.324

8.  Intralipid/heparin infusion suppresses serum leptin in humans.

Authors:  P Garcia-Lorda; Wendy Nash; Ansley Roche; F-X Pi-Sunyer; B Laferrere
Journal:  Eur J Endocrinol       Date:  2003-06       Impact factor: 6.664

9.  Plasma and red blood cells membrane lipid concentration of sickle cell disease patients.

Authors:  Zuhair M Marzouki; Samir M Khoja
Journal:  Saudi Med J       Date:  2003-04       Impact factor: 1.484

10.  Plasma and red cell lipids in sickle cell disease.

Authors:  P A Akinyanju; C O Akinyanju
Journal:  Ann Clin Lab Sci       Date:  1976 Nov-Dec       Impact factor: 1.256

View more
  13 in total

1.  Featured Article: Alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood.

Authors:  Eric Soupene; Mark S Borja; Mauricio Borda; Sandra K Larkin; Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2016-06-27

2.  Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients.

Authors:  Oktay H Ozturk; Yesim Can; Zafer Yonden; Sedat Motor; Gonul Oktay; Hasan Kaya; Mutay Aslan
Journal:  Lipids       Date:  2013-10-11       Impact factor: 1.880

3.  Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension.

Authors:  Suzana Zorca; Lita Freeman; Mariana Hildesheim; Darlene Allen; Alan T Remaley; James G Taylor; Gregory J Kato
Journal:  Br J Haematol       Date:  2010-03-08       Impact factor: 6.998

4.  Hypocholesterolemia is associated negatively with hemolysate lipid peroxidation in sickle cell anemia patients.

Authors:  Y E Oztas; Oztas Er Yesim; S Sabuncuoglu; Sabuncuoglu Suna; S Unal; Unal Selma; H Ozgunes; Ozgunes Hilal; N Ozgunes; Ozgunes Nuriman
Journal:  Clin Exp Med       Date:  2010-12-30       Impact factor: 3.984

5.  Featured Article: Depletion of HDL3 high density lipoprotein and altered functionality of HDL2 in blood from sickle cell patients.

Authors:  Eric Soupene; Sandra K Larkin; Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-24

6.  Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine.

Authors:  Fekri Samarah; Mahmoud A Srour; Kamal Dumaidi
Journal:  Biomed Res Int       Date:  2021-08-04       Impact factor: 3.411

7.  Defective lipid metabolism in sickle cell anaemia subjects in vaso-occlusive crisis.

Authors:  Kehinde Sola Akinlade; Christiana Odunayo Adewale; Sheu Kadiri Rahamon; Foluke Atinuke Fasola; John Ayodele Olaniyi; Adedeji David Atere
Journal:  Niger Med J       Date:  2014-09

8.  Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia.

Authors:  Milena Magalhães Aleluia; Caroline Conceição da Guarda; Rayra Pereira Santiago; Teresa Cristina Cardoso Fonseca; Fábia Idalina Neves; Regiana Quinto de Souza; Larissa Alves Farias; Felipe Araújo Pimenta; Luciana Magalhães Fiuza; Thassila Nogueira Pitanga; Júnia Raquel Dutra Ferreira; Elisângela Vitória Adorno; Bruno Antônio Veloso Cerqueira; Marilda de Souza Gonçalves
Journal:  Lipids Health Dis       Date:  2017-04-11       Impact factor: 3.876

9.  Normal Non-HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case-Control Study of Tema Metropolis.

Authors:  Richard K D Ephraim; Patrick Adu; Edem Ake; Hope Agbodzakey; Prince Adoba; Obed Cudjoe; Clement Agoni
Journal:  J Lipids       Date:  2016-12-18

Review 10.  Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease.

Authors:  Robert P Hebbel; Gregory M Vercellotti
Journal:  Am J Hematol       Date:  2021-08-23       Impact factor: 13.265

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.